Methylprednisolone
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 11 |
Source: | FDA Structured Product Label |
---|
Side effects: | 16 |
Source: | FDA Structured Product Label |
---|
Side effects: | 20 |
Source: | FDA Structured Product Label |
---|
Side effects: | 40 |
Source: | Health Canada |
---|
Side effects: | 40 |
Source: | FDA Structured Product Label |
---|
Side effects: | 40 |
Source: | FDA Structured Product Label |
---|
Side effects: | 41 |
Source: | FDA Structured Product Label |
---|
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 50 |
Source: | FDA Structured Product Label |
---|
Side effects: | 50 |
Source: | FDA Structured Product Label |
---|
Side effects: | 93 |
Source: | FDA Structured Product Label |
---|
Side effects: | 93 |
Source: | FDA Structured Product Label |
---|
Side effects: | 94 |
Source: | FDA Structured Product Label |
---|
Side effects: | 95 |
Source: | FDA Structured Product Label |
---|
Side effects: | 95 |
Source: | FDA Structured Product Label |
---|
Side effects: | 95 |
Source: | FDA Structured Product Label |
---|
Side effects: | 95 |
Source: | FDA Structured Product Label |
---|
Side effects: | 115 |
Source: | Medsafe |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|